Renew Biopharma, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Renew Biopharma, Inc. is a biotechnology company focused on developing therapies for neuroinflammation, with an emphasis on traumatic brain injury. Based in San Diego, California, the firm employs a small team and is advancing a proprietary enzymatic platform to generate a pipeline of therapeutic molecules that can cross the blood–brain barrier and engage a cellular receptor involved in inflammatory regulation. Its approach contrasts with traditional medicinal chemistry by utilizing engineered enzymatic reactions to efficiently produce alkylresorcinol derivative compounds, potentially enabling scalable creation of neurotherapeutic candidates. The company holds an intellectual property portfolio related to enzymes and engineered variants used for prenylation processes that generate these derivatives. A notable recent development is the appointment of a new chief operating officer in 2020, reflecting ongoing organizational progress. The company positions itself within the biotechnology research industry as a developer of targeted neuroinflammation therapies, aiming to address indications with unmet medical needs, such as TBI, where no FDA-approved drug treatment currently exists.

Sign up for free to view info

Email Format Employee directory